These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 5019629)

  • 41. L-dopa and the patient with Parkinson's disease.
    Fangman A; O'Malley WE
    Am J Nurs; 1969 Jul; 69(7):1455-7. PubMed ID: 5192672
    [No Abstract]   [Full Text] [Related]  

  • 42. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
    Mones RJ; Elizan TS
    J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089
    [No Abstract]   [Full Text] [Related]  

  • 43. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
    Dumas R; Rahme M; Schott B
    J Med Lyon; 1971 Apr; 52(207):599-615. PubMed ID: 5136571
    [No Abstract]   [Full Text] [Related]  

  • 44. [Results of psychometic tests in 23 patients with Parkinson's disease after 6 months treatment with L-dopa].
    Barbizet J; Duizabo P; Pasquier M
    Rev Neurol (Paris); 1972 Aug; 127(2):311-3. PubMed ID: 4666638
    [No Abstract]   [Full Text] [Related]  

  • 45. L-dopa and parkinsonism.
    Okihiro MM
    Hawaii Med J; 1971; 30(5):390-2. PubMed ID: 5160226
    [No Abstract]   [Full Text] [Related]  

  • 46. Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease.
    Hare TA; Vanna S; Beasley B; Chambers R; Vogel WH
    J Lab Clin Med; 1971 Feb; 77(2):319-25. PubMed ID: 5540775
    [No Abstract]   [Full Text] [Related]  

  • 47. [The Rey complex picture test in evaluation of some effects induced by treatment with L-dopa in patients with parkinsonism].
    Megna GF; Puca FM; Micalizzi V; Leggiadro N; Di Rosa AE
    Acta Neurol (Napoli); 1971; 26(4):473-83. PubMed ID: 4943712
    [No Abstract]   [Full Text] [Related]  

  • 48. [Parkinsonism and L-dopa: our 1st results].
    Warot P; Petit H; Chevalier-Lefebvre J; Herbaut G
    Lille Med; 1971 May; 16(5):765-7. PubMed ID: 5115349
    [No Abstract]   [Full Text] [Related]  

  • 49. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.
    Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744
    [No Abstract]   [Full Text] [Related]  

  • 50. [L-dopa effect in Parkinson's syndrome].
    Römer F; Bettag W; Bock WJ
    Z Allgemeinmed; 1971 Feb; 47(6):281-3. PubMed ID: 5571715
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa].
    Bergamini L; Bonzanino A; Bignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):10-6. PubMed ID: 5524931
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
    De Divitiis E; Cerillo A; Tata MR; Decina A
    Acta Neurol (Napoli); 1973; 28(2):208-12. PubMed ID: 4709076
    [No Abstract]   [Full Text] [Related]  

  • 53. [Analysis of the effects of L-dopa during a 3-month course of treatment].
    Pinto F; Venturini E
    Riv Neurobiol; 1970; 16(4):415-28. PubMed ID: 4949926
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T
    No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract]   [Full Text] [Related]  

  • 55. Observations on patients with Parkinson's disease treated with L-dopa. I. Trial and evaluation of L-dopa therapy.
    van Wieringen A; Wright J
    S Afr Med J; 1972 Sep; 46(35):1262-6. PubMed ID: 4638222
    [No Abstract]   [Full Text] [Related]  

  • 56. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J
    J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
    Sugita K; Mutsuga N; Takaoka Y; Takeda A
    No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical electroencephalographic studies during the treatment of parkinsonism with an L-DOPA preparation].
    Krasnov EA; Romenskaia LKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):520-3. PubMed ID: 4705406
    [No Abstract]   [Full Text] [Related]  

  • 59. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa].
    Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT
    Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of parkinsonism with L-dopa].
    Presthus J
    Nord Med; 1970 Nov; 84(46):1467-8. PubMed ID: 5479940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.